Solid Biosciences Inc. SLDB Proceeds From Issuance Of Common Stock In At The Market Public Offering Net Of Sales Commissions
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept sldb:ProceedsFromIssuanceOfCommonStockInAtTheMarketPublicOfferingNetOfSalesCommissions.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s proceeds from issuance of common stock in at the market public offering net of sales commissions.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s proceeds from issuance of common stock in at the market public offering net of sales commissions?
- Solid Biosciences Inc. (SLDB) reported proceeds from issuance of common stock in at the market public offering net of sales commissions of $11.93M in Q1 2026.
- How has Solid Biosciences Inc.'s proceeds from issuance of common stock in at the market public offering net of sales commissions changed year-over-year?
- Solid Biosciences Inc.'s proceeds from issuance of common stock in at the market public offering net of sales commissions increased by 4748.4% year-over-year, from $246K to $11.93M.